ISPOR—The Professional Society for Health Economics and Outcomes Research - Comprehensive Analysis Report

Summary

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) is a global, nonprofit organization founded in 1995 dedicated to advancing health economics and outcomes research. ISPOR's mission is to advance HEOR excellence to improve decision-making for health globally. The Society envisions a world where healthcare is accessible, effective, efficient, and affordable for all. ISPOR is a source for scientific conferences, publications, good practices guidance, education, collaboration, and resources in the field.

1. Strategic Focus & Objectives

Core Objectives

Advance the science, policy, and practice of health economics and outcomes research to promote informed healthcare decision-making.

Strive for a world where healthcare is accessible, effective, efficient, and affordable for all.

Serve as an unbiased resource and catalyst for innovation in the field.

Implement Strategic Plan 2030, which presents a vision for the Society and the field of HEOR.

Specialization Areas

Advancing health economics and outcomes research.

Providing resources and education in the field.

Facilitating collaboration among various stakeholders.

Target Markets

Academic institutions.

Public and private health insurers.

Governments.

Patient organizations.

Biopharmaceutical, biotechnology, medical devices and diagnostics companies.

Nongovernmental organizations.

2. Financial Overview

Funding History

As a nonprofit, ISPOR's financial backing comes from:

Membership dues.

Conference revenue (registration, exhibits, and sponsorships).

Participation from individuals and organizations that share its mission.

3. Product Pipeline

Key Products/Services

Scientific conferences.

Peer-reviewed and indexed publications.

Good practices guidance.

Education.

Collaboration.

Tools/resources.

4. Technology & Innovation

Technology Stack

Focus on artificial intelligence (AI) and its applications within HEOR.

Laser AI, an AI-assisted evidence synthesis management tool.

GRADEpro guideline development tool.

5. Leadership & Management

Executive Team

Dr. Uwe Siebert: President (2025-2026)

Dr. Beth Devine: President-Elect (2025-2026)

Dr. Eberechukwu Onukwugha: Past President (2025-2026)

Rob Abbott: CEO and Executive Director

Recent Leadership Changes

In May 2023, Brian O'Rourke assumed the role of President.

In May 2024, Eberechukwu Onukwugha assumed the role of President; Uwe Siebert was elected as President-Elect.

In May 2025, Uwe Siebert assumed the role of President; Beth Devine was elected as President-Elect.

6. Competitive Analysis

Major Competitors

Academy of Managed Care Pharmacy (AMCP).

The National Pharmaceutical Council (NPC).

Institute for Clinical and Economic Review (ICER).

National Health Council.

Society for Medical Decision Making.

7. Market Analysis

Market Overview

The market for health economics and outcomes research is driven by:

The increasing need to make informed healthcare decisions.

Rising costs.

Technological advancements.

Evolving patient expectations.

Affordability and its impact on the long-term sustainability of healthcare systems.

Digital health and its influence on the transformation of healthcare.

Whole health and its potential to improve the well-being of people across the globe.

8. Strategic Partnerships

For each significant partnership:

Society for Medical Decision Making: collaboration to develop a comprehensive list of papers that outline the ideal practice for developing decision analytic models for pharmacoeconomic analysis.

Academy of Managed Care Pharmacy: collaboration to develop guidelines for training programs and fellowships for future professionals in pharmacoeconomics and outcomes research.

Food and Drug Administration (FDA): Joint summit on the topic of patient preference information in medical device regulatory decisions.

9. Operational Insights

Guided by its mission to improve healthcare decisions through rigorous scientific research.

Multistakeholder perspective: increasing the understanding and application of HEOR to improve healthcare decisions.

Transparency and Reproducibility: initiative to recognize transparency in research for papers published in Value in Health.

Adheres to the principles on conflict of interest promulgated by the International Committee of Medical Journal Editors.

10. Future Outlook

Strategic Roadmap

Focuses on the new vision for the Society of a world where healthcare is accessible, effective, efficient, and affordable for all through Strategic Plan 2030.